Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Molecular Profiling of Extramedullary and Medullary Plasmacytomas Compared to Multiple Myeloma

Anuj Mahindra, MD, Samir B. Amin, MBBS, Aliyah R. Sohani, MD, Gabriela Motyckova, MD, PhD, Kishan Patel, Sonia Vallet, MD, Samantha Pozzi, Loredana Santo, Diana Cirstea, M.D., Christiana E. Toomey, James S. Michaelson, PhD, Ephraim P. Hochberg, MD, Paola Dal Cin, PhD, Scott J Rodig, Teru Hideshima, Kenneth C. Anderson, Nikhil C. Munshi, MD, Noopur Raje, MD

Blood (2010) 116 (21): 4042.

https://doi.org/10.1182/blood.V116.21.4042.4042

Published: 2010

Journal Articles

Inhibition of Histone Deacetylase 6 Effects on Interaction of Tumor and Immune Cells In Multiple Myeloma

Gullu Gorgun, PhD, Teru Hideshima, MD, PhD, Naoya Mimura, MD, PhD, Diana Cirstea, M.D., Loredana Santo, MD, Yiguo Hu, MD, PhD, Claire Fabre, MD, Noopur Raje, MD, Nikhil C. Munshi, MD, Paul G Richardson, MD, Kenneth C. Anderson, MD

Blood (2010) 116 (21): 2996.

https://doi.org/10.1182/blood.V116.21.2996.2996

Published: 2010

Journal Articles

Selective Inhibition of HDAC6 with a New Prototype Inhibitor (ACY-1215) Overcomes Bortezomib Resistance In Multiple Myeloma (MM)

Loredana Santo, MD, Teru Hideshima, MD, PhD, Andrew L. Kung, MD, PhD, Matthew Jarpe, PhD, Diana Cirstea, M.D., Kishan Patel, Samantha Pozzi, MD, Jen C. Tseng, PhD, Scott J Rodig, James Bradner, M.D., Kenneth C. Anderson, MD, Simon Jones, PhD, Noopur Raje, MD

Blood (2010) 116 (21): 2997.

https://doi.org/10.1182/blood.V116.21.2997.2997

Published: 2010

Journal Articles

CYC065, a Potent Derivative of Seliciclib Is Active In Multiple Myeloma In Preclinical Studies

Samantha Pozzi, MD, Diana Cirstea, M.D., Loredana Santo, MD, Doris M Nabikejje, Kishan Patel, Kathryn M Luly, Gaurav Gharti-Chhetry, Sonia Vallet, MD, Homare Eda, MD, PhD, Teru Hideshima, MD, Simon R Green, Kenneth C. Anderson, MD, David T. Scadden, MD, Noopur Raje, MD

Blood (2010) 116 (21): 2999.

https://doi.org/10.1182/blood.V116.21.2999.2999

Published: 2010

Journal Articles

Combination of Nab -Rapamycin and Perifosine Induces Synergistic Cytotoxicity and Antitumor Activity Via Autophagy and Apoptosis in Multiple Myeloma (MM)

Blood (2008) 112 (11): 3663.

https://doi.org/10.1182/blood.V112.11.3663.3663

Published: 2008

Journal Articles

RGB 286638, a Novel Multi-Targeted Small Molecule Inhibitor, Induces Multiple Myeloma (MM) Cell Death through Abrogation of CDKDependent and Independent Survival Mechanisms

Diana Cirstea, M.D., Teru Hideshima, M.D., Ph.D., Samantha Pozzi, M.D., Sonia Vallet, M.D., Hiroshi Ikeda, M.D., Ph.D., Loredana Santo, M.D., Hannes Loferer, Nileshwari Vaghela, M.B.S., Yutaka Okawa, M.D., Ph.D., Giulia Perrone, M.D., Gullu Gorgun, Ph.D., Elisabetta Calabrese, M.D., Nikhil C. Munshi, MD, Kenneth C. Anderson, M.D., Noopur Raje, M.D.

Blood (2008) 112 (11): 2759.

https://doi.org/10.1182/blood.V112.11.2759.2759

Published: 2008

Journal Articles

Molecular Profiling of Extramedullary and Medullary Plasmacytomas

Gabriela Motyckova, M.D., Ph.D., Aliyah Rahemtullah, M.D., Nileshwari Vaghela, M.S., Sonia Vallet, M.D., Adam Ackerman, Siddhartha Mukherjee, M.D., Ph.D., Samantha Pozzi, M.D., Loredana Santo, Ph.D., Diana Cirstea, M.D., Christiana Toomey, Ephraim P. Hochberg, M.D., Paola Dal Cin, Ph.D., Scott Rodig, M.D., Ph.D., Teru Hideshima, M.D., Ph.D., Kenneth C Anderson, M.D., Nikhil Munshi, M.D., Noopur Raje, M.D.

Blood (2008) 112 (11): 5111.

https://doi.org/10.1182/blood.V112.11.5111.5111

Published: 2008

NARROW

Molecular Profiling of Extramedullary and Medullary Plasmacytomas Compared to Multiple Myeloma

Inhibition of Histone Deacetylase 6 Effects on Interaction of Tumor and Immune Cells In Multiple Myeloma

Selective Inhibition of HDAC6 with a New Prototype Inhibitor (ACY-1215) Overcomes Bortezomib Resistance In Multiple Myeloma (MM)

CYC065, a Potent Derivative of Seliciclib Is Active In Multiple Myeloma In Preclinical Studies

Combination of Nab -Rapamycin and Perifosine Induces Synergistic Cytotoxicity and Antitumor Activity Via Autophagy and Apoptosis in Multiple Myeloma (MM)

RGB 286638, a Novel Multi-Targeted Small Molecule Inhibitor, Induces Multiple Myeloma (MM) Cell Death through Abrogation of CDKDependent and Independent Survival Mechanisms

Molecular Profiling of Extramedullary and Medullary Plasmacytomas

Email alerts

ASH Publications

American Society of Hematology

Molecular Profiling of Extramedullary and Medullary Plasmacytomas Compared to Multiple Myeloma

Inhibition of Histone Deacetylase 6 Effects on Interaction of Tumor and Immune Cells In Multiple Myeloma

Selective Inhibition of HDAC6 with a New Prototype Inhibitor (ACY-1215) Overcomes Bortezomib Resistance In Multiple Myeloma (MM)

CYC065, a Potent Derivative of Seliciclib Is Active In Multiple Myeloma In Preclinical Studies

Combination of Nab -Rapamycin and Perifosine Induces Synergistic Cytotoxicity and Antitumor Activity Via Autophagy and Apoptosis in Multiple Myeloma (MM)

RGB 286638, a Novel Multi-Targeted Small Molecule Inhibitor, Induces Multiple Myeloma (MM) Cell Death through Abrogation of CDKDependent and Independent Survival Mechanisms

Molecular Profiling of Extramedullary and Medullary Plasmacytomas

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only